Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 72 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8383633

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  2. US 8377945

    Small molecule inhibitors of spleen tyrosine kinase (SYK)

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  3. US 8377924

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  4. US 8377872

    Cyclic P3 tripeptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  5. US 8377926

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  6. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  7. US 8372873

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  8. US 8372850

    Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  9. US 8372835

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  10. US 8367697

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  11. US 8362043

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  12. US 8361958

    Oximyl HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  13. US 8354538

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted
  14. US 8349899

    Selective inhibitors of EG5 motors and methods of use

    Arrowhead Center, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  15. US 8349838

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  16. US 8344153

    Inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  17. US 8343952

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  18. US 8338462

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  19. US 8338597

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  20. US 8338461

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  21. US 8338412

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  22. US 8329745

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  23. US 8329900

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  24. US 8324258

    F1F0-ATPase inhibitors and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted